loader
Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering Eribulin

Menu
$ API Ref.Price (USD/KG) : 14,161,255Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3EISAI INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Luxepack
Not Confirmed
arrow
Luxepack
Not Confirmed

ERIBULIN MESYLATE

US Patent Number : RE46965

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 201532

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-01-08

blank

02

arrow
Luxepack
Not Confirmed
arrow
Luxepack
Not Confirmed

ERIBULIN MESYLATE

US Patent Number : 6214865*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 201532

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-01-20

blank

03

arrow
Luxepack
Not Confirmed
arrow
Luxepack
Not Confirmed

ERIBULIN MESYLATE

US Patent Number : RE46965*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 201532

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-07-08

blank